ID

27854

Description

Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01027065

Lien

https://clinicaltrials.gov/show/NCT01027065

Mots-clés

Versions (1)
  1. 01/12/2017 01/12/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

1 décembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Hepatitis B NCT01027065

Anglais

Eligibility Chronic Hepatitis B NCT01027065

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic hbv-infected patients
Description

Hepatitis B, Chronic

Type de données

boolean

Alias
UMLS CUI [1]
C0524909
hbeag-negative patients
Description

Hepatitis B e antigen negative

Type de données

boolean

Alias
UMLS CUI [1]
C0948827
age > 18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
patients with active chronic hepatitis at the start of the antiviral treatment
Description

Hepatitis, Chronic | Antiviral Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0019189
UMLS CUI [2]
C0280274
patient with a hbv dna undetectable (<70 copies/ml) stable for at least 3 months under entecavir or tenofovir treatment.
Description

Hepatitis B virus DNA Undetectable | Entecavir Stable | Tenofovir Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0369332
UMLS CUI [1,2]
C3827727
UMLS CUI [2,1]
C0971023
UMLS CUI [2,2]
C0205360
UMLS CUI [3,1]
C0384228
UMLS CUI [3,2]
C0205360
ongoing treatment by entecavir or tenofovir at screening note: previous treatment with pegylated ifn monotherapy, before the start of entecavir or tenofovir, is acceptable
Description

entecavir | Tenofovir | Pegylated interferon alfa Acceptable

Type de données

boolean

Alias
UMLS CUI [1]
C0971023
UMLS CUI [2]
C0384228
UMLS CUI [3,1]
C0907160
UMLS CUI [3,2]
C1879533
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
infection by hcv
Description

Hepatitis C

Type de données

boolean

Alias
UMLS CUI [1]
C0019196
infection by hiv-1 and /or hiv-2
Description

HIV-1 infection | HIV-2 infection

Type de données

boolean

Alias
UMLS CUI [1]
C2363741
UMLS CUI [2]
C0854094
apart from hbv infection, presence of active infection requiring a specific treatment or a hospitalization
Description

Communicable Disease Requirement Therapeutic procedure Specific | Communicable Disease Hospitalization Required | Exception Hepatitis B

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0205369
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C1708385
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0019163
previous treatment by lamivudine and/or nucleosides analogues
Description

Lamivudine | Nucleoside Analogs

Type de données

boolean

Alias
UMLS CUI [1]
C0209738
UMLS CUI [2]
C1579410
inactive carrier
Description

Carrier Without Activity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0560175
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C0205177
cirrhosis
Description

Liver Cirrhosis

Type de données

boolean

Alias
UMLS CUI [1]
C0023890
other liver disease (notably from alcoholic, metabolic or immunological origin)
Description

Liver disease Other | Alcoholic Liver Diseases | Liver disease Cause Metabolic | Liver disease Cause immunological

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C0023896
UMLS CUI [3,1]
C0023895
UMLS CUI [3,2]
C0015127
UMLS CUI [3,3]
C0311400
UMLS CUI [4,1]
C0023895
UMLS CUI [4,2]
C0015127
UMLS CUI [4,3]
C0205470
history of clinical autoimmune disease or active auto-immune disease
Description

Autoimmune Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0004364
type i diabetes mellitus
Description

Diabetes Mellitus, Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
severe asthma, presently on chronic medications
Description

Severe asthma | Pharmaceutical Preparations chronic

Type de données

boolean

Alias
UMLS CUI [1]
C0581126
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0205191
Retour au début de la page

Similar models

Eligibility Chronic Hepatitis B NCT01027065

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis B, Chronic
Item
chronic hbv-infected patients
boolean
C0524909 (UMLS CUI [1])
Hepatitis B e antigen negative
Item
hbeag-negative patients
boolean
C0948827 (UMLS CUI [1])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Hepatitis, Chronic | Antiviral Therapy
Item
patients with active chronic hepatitis at the start of the antiviral treatment
boolean
C0019189 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
Hepatitis B virus DNA Undetectable | Entecavir Stable | Tenofovir Stable
Item
patient with a hbv dna undetectable (<70 copies/ml) stable for at least 3 months under entecavir or tenofovir treatment.
boolean
C0369332 (UMLS CUI [1,1])
C3827727 (UMLS CUI [1,2])
C0971023 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0384228 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
entecavir | Tenofovir | Pegylated interferon alfa Acceptable
Item
ongoing treatment by entecavir or tenofovir at screening note: previous treatment with pegylated ifn monotherapy, before the start of entecavir or tenofovir, is acceptable
boolean
C0971023 (UMLS CUI [1])
C0384228 (UMLS CUI [2])
C0907160 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hepatitis C
Item
infection by hcv
boolean
C0019196 (UMLS CUI [1])
HIV-1 infection | HIV-2 infection
Item
infection by hiv-1 and /or hiv-2
boolean
C2363741 (UMLS CUI [1])
C0854094 (UMLS CUI [2])
Communicable Disease Requirement Therapeutic procedure Specific | Communicable Disease Hospitalization Required | Exception Hepatitis B
Item
apart from hbv infection, presence of active infection requiring a specific treatment or a hospitalization
boolean
C0009450 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2,1])
C1708385 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
Lamivudine | Nucleoside Analogs
Item
previous treatment by lamivudine and/or nucleosides analogues
boolean
C0209738 (UMLS CUI [1])
C1579410 (UMLS CUI [2])
Carrier Without Activity
Item
inactive carrier
boolean
C0560175 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0205177 (UMLS CUI [1,3])
Liver Cirrhosis
Item
cirrhosis
boolean
C0023890 (UMLS CUI [1])
Liver disease Other | Alcoholic Liver Diseases | Liver disease Cause Metabolic | Liver disease Cause immunological
Item
other liver disease (notably from alcoholic, metabolic or immunological origin)
boolean
C0023895 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0023896 (UMLS CUI [2])
C0023895 (UMLS CUI [3,1])
C0015127 (UMLS CUI [3,2])
C0311400 (UMLS CUI [3,3])
C0023895 (UMLS CUI [4,1])
C0015127 (UMLS CUI [4,2])
C0205470 (UMLS CUI [4,3])
Autoimmune Disease
Item
history of clinical autoimmune disease or active auto-immune disease
boolean
C0004364 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type i diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Severe asthma | Pharmaceutical Preparations chronic
Item
severe asthma, presently on chronic medications
boolean
C0581126 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial